Title : miR-34c Targets MET to Improve the Anti-Tumor Effect of Cisplatin on Ovarian Cancer.

Pub. Date : 2020

PMID : 32308421






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Conclusion: miR-34c/MET axis promotes cisplatin-induced cytotoxicity against ovarian cancer by targeting the MET/PI3K/AKT/Bad pathway. Cisplatin AKT serine/threonine kinase 1 Homo sapiens